Search results
Eli Lilly Shares Jump After It Signals Increase in Production of Obesity, Diabetes Drugs
The Wall Street Journal· 3 days agoSales of diabetes drugs Mounjaro and Trulicity came in lower than analysts expected, which BMO...
Eli Lilly and Co (LLY) Surpasses Q1 Earnings Estimates and Raises Full-Year Guidance
GuruFocus.com via Yahoo Finance· 3 days agoHowever, the company faced challenges with Trulicity, whose sales declined due to supply constraints...
Chasing Novo and Lilly: The obesity drugs that could challenge Wegovy and Zepbound
BioPharma Dive via Yahoo Finance· 3 days agoLarge and small drugmakers are vying for a piece of what analysts view as one of the biggest market...
Denmark to restrict Ozempic, other GLP-1 drugs, to treat type 2 diabetes
Reuters· 2 days agoIn 2023, 50% of new patients suffering from type 2 diabetes began treatment with a reimbursed GLP-1...
Q1 2024 Eli Lilly and Co Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 2 days agoU.S. revenue increased 28% in Q1 driven by growth of Mounjaro, Zepbound and Verzenio. Unprecedented demand for our incretin medicines led to wholesaler backorders of Trulicity
Lilly rides Mounjaro, Zepbound to better-than-expected 1Q profit despite supply issues
WMBD - FOX 43 Peoria· 3 days agoRapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro,...
Eli Lilly Stock Jumps After It Signals Rise in Obesity and Diabetes Drugs Production
The Wall Street Journal· 3 days agoSupply constraints for a popular class of diabetes and obesity drugs limited **Eli Lilly**’s...
Lilly reports earnings, raises forecast | Arkansas Democrat Gazette
Arkansas Democrat-Gazette· 2 days agoRapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro,...
Goldman Scrutinizes Hits, Misses, And Growth Trajectory Concerns For Eli Lilly And Its Its Obesity...
Benzinga· 2 days agoTuesday, Eli Lilly And Co LLY reported first-quarter revenue of $8.77 billion, up 26% year over...
Board trying to lower drug costs urges Marylanders to help ‘fill in’ info gaps
Maryland Matters via Yahoo News· 3 days agoThe Prescription Drug Affordability Board is seeking feedback from patients, physicians and manufactures to provide context and first-hand experience about trying to afford medications for certain ...
